Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Stealth’s Forzinity: Barth Syndrome Drug’s Uncertain Efficacy Split US FDA
Oct 31 2025
•
By
Sue Sutter
The FDA granted accelerated approval to Stealth's Barth syndrome drug Forzinity based on knee extensor muscle strength.
(Nancy Pham)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Drug Review Profiles
More from United States